BIOXYTRAN, INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2012 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Bioxytran, Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2012 to Q4 2024.
  • Bioxytran, Inc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$512K, a 55.4% increase year-over-year.
  • Bioxytran, Inc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was -$2.37M, a 47.1% increase year-over-year.
  • Bioxytran, Inc annual Net Income (Loss) Attributable to Parent for 2024 was -$2.37M, a 47.1% increase from 2023.
  • Bioxytran, Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$4.47M, a 80.8% decline from 2022.
  • Bioxytran, Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$2.47M, a 38.7% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 -$2.37M -$512K +$635K +55.4% Oct 1, 2024 Dec 31, 2024 10-K 2025-04-03
Q3 2024 -$3M -$392K +$701K +64.1% Jul 1, 2024 Sep 30, 2024 10-Q 2024-10-29
Q2 2024 -$3.7M -$662K +$786K +54.3% Apr 1, 2024 Jun 30, 2024 10-Q 2024-10-29
Q1 2024 -$4.49M -$800K -$15.2K -1.94% Jan 1, 2024 Mar 31, 2024 10-Q 2024-10-29
Q4 2023 -$4.47M -$1.15M -$332K -40.8% Oct 1, 2023 Dec 31, 2023 10-K 2025-04-03
Q3 2023 -$4.14M -$1.09M -$969K -784% Jul 1, 2023 Sep 30, 2023 10-Q 2024-10-29
Q2 2023 -$3.17M -$1.45M -$825K -133% Apr 1, 2023 Jun 30, 2023 10-Q 2024-10-29
Q1 2023 -$2.35M -$785K +$127K +13.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-10-29
Q4 2022 -$2.47M -$815K +$223K +21.5% Oct 1, 2022 Dec 31, 2022 10-K/A 2025-01-13
Q3 2022 -$2.7M -$124K +$352K +74% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 -$3.05M -$622K +$274K +30.6% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-03
Q1 2022 -$3.32M -$912K +$709K +43.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-03
Q4 2021 -$4.03M -$1.04M -$167K -19.1% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$3.86M -$475K -$273K -135% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$3.59M -$897K +$31.9K +3.44% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$3.62M -$1.62M -$1.08M -200% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$2.54M -$871K -$209K -31.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-04-11
Q3 2020 -$2.33M -$202K +$672K +76.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-17
Q2 2020 -$3.01M -$929K -$798K -613% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-10
Q1 2020 -$2.21M -$540K -$349K -182% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 -$1.86M -$663K -$1.08M -257% Oct 1, 2019 Dec 31, 2019 10-K 2021-04-09
Q3 2019 -$774K -$874K -$827K -1739% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-13
Q2 2019 $52.2K -$130K -$130K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $182K -$191K +$479K +71.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-13
Q4 2018 -$296K $421K +$508K Oct 1, 2018 Dec 31, 2018 10-K 2020-03-18
Q3 2018 -$804K -$47.5K -$96.4K -197% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-13
Q2 2018 -$708K -$275* +$260K Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$968K -$670K -$605K -937% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$363K -$86.4K -$222K -164% Oct 5, 2017 Dec 31, 2017 10-K 2019-03-13
Q3 2017 -$141K $48.9K +$263K Jul 1, 2017 Sep 30, 2017 10-Q 2017-11-07
Q2 2017 -$404K -$260K -$97.4K -59.8% Apr 1, 2017 Jun 30, 2017 10-Q 2018-07-31
Q1 2017 -$306K -$64.6K +$390K +85.8% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$697K $135K +$250K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 -$947K -$214K -$184K -611% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 -$763K -$163K +$1.75M +91.5% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 -$2.52M -$455K -$416K -1065% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-15
Q4 2015 -$2.1M -$115K +$120K +51.1% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-31
Q3 2015 -$2.22M -$30.1K +$1.09M +97.3% Jul 1, 2015 Sep 30, 2015 10-Q 2016-12-09
Q2 2015 -$3.31M -$1.92M -$1.86M -3195% Apr 1, 2015 Jun 30, 2015 10-Q 2016-09-20
Q1 2015 -$1.45M -$39.1K -$102K -162% Jan 1, 2015 Mar 31, 2015 10-Q 2016-09-20
Q4 2014 -$1.35M -$235K -$347K -311% Oct 1, 2014 Dec 31, 2014 10-Q 2016-09-20
Q3 2014 -$1M -$1.12M -$839K -303% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 -$161K -$58.2K +$581K +90.9% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-19
Q1 2014 -$742K $62.8K +$1.04M Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-14
Q4 2013 -$1.78M $112K +$785K Oct 1, 2013 Dec 31, 2013 10-K 2015-04-10
Q3 2013 -$2.56M -$277K +$210K +43.1% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-13
Q2 2013 -$2.77M -$639K +$27K +4.06% Mar 31, 2013 Jun 30, 2013 10-Q 2014-08-12
Q1 2013 -$2.8M -$974K -$507K -109% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-14
Q4 2012 -$2.29M -$673K Oct 1, 2012 Dec 31, 2012 10-K 2014-04-14
Q3 2012 -$487K Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-18
Q2 2012 -$666K Mar 31, 2012 Jun 30, 2012 10-Q 2013-08-15
Q1 2012 -$467K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.